Skip to main content
. 2020 Aug 20;64(9):e00773-20. doi: 10.1128/AAC.00773-20

FIG 2.

FIG 2

Effect of DAAs on the levels of soluble biomarkers. sCD163, β2-microglobulin (β2-M), and D-dimer levels were reduced after DAA therapy. The Wilcoxon test was used to compare HIV/HCV-coinfected patients at baseline (BL) and at the end of treatment (ET). The Mann-Whitney U test was used to compare HIV/HCV-coinfected patients and the HIV-monoinfected patient control group (Ctrl). **, P < 0.001.